PFE: Pfizer Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 148,711.01
Enterprise Value ($M) 212,738.01
Book Value ($M) 92,558.00
Book Value / Share 16.33
Price / Book 1.61
NCAV ($M) -74,541.00
NCAV / Share -13.15
Price / NCAV -2.00

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.08

Liquidity (mrq)
Quick Ratio 0.92
Current Ratio 1.17

Balance Sheet (mrq) ($M)
Current Assets 50,358.00
Assets 213,396.00
Liabilities 124,899.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 63,627.00
Operating Income 16,328.00
Net Income 8,031.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 12,744.00
Cash from Investing 2,652.00
Cash from Financing -17,140.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2024-02-13 13G/A Vanguard Group Inc 8.97 0.97

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 8,801,874 48,219,947 18.25
2025-03-06 7,049,468 35,638,777 19.78
2025-03-05 5,184,954 30,250,360 17.14
2025-03-04 8,774,275 37,170,828 23.61
2025-03-03 9,251,093 43,937,593 21.06

(click for more detail)

Similar Companies
NUVB – Nuvation Bio Inc. OGN – Organon & Co.
PBH – Prestige Consumer Healthcare Inc. PRGO – Perrigo Company plc
QGEN – Qiagen N.V.


Financial data and stock pages provided by
Fintel.io